PFN1 and amyotrophic lateral sclerosis: In summary, ALS-associated PFN1 mutants possess toxic gain-of-function of which particularly the formation of amyloid-like protein aggregates with TDP43, but potentially, also additional properties of monomeric PFN1 mutants, cause the ALS pathology.